Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees
2025 · 3rd Quarter (July 1 - Sep 30)
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
Filed by PROFESSIONAL COMPOUNDING CENTERS OF AMERICA.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- $140,000.00
- Filing UUID
- e7750665-6204-4f1c-a98d-4312b3bfed11
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill
Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025
Literal federal measure citations: H.R. 5316
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.